Berbice Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4K Hold
20
0.01% 120
2025
Q4
$21.5K Hold
20
0.01% 108
2025
Q3
$15.3K Sell
20
-612
-97% -$455K 0.01% 150
2025
Q2
$493K Sell
632
-260
-29% -$202K 0.35% 30
2025
Q1
$737K Buy
892
+20
+2% +$16.6K 0.63% 23
2024
Q4
$673K Buy
+872
New +$722K 0.54% 25

Other funds holding LLY

Berbice Capital Management's LLY Position: Q1 2026 in Review

Berbice Capital Management held its Eli Lilly (LLY) position steady in Q1 2026 at 20 shares worth $18.4K. The position accounts for 0.01% of the portfolio, ranked #120.

Berbice Capital Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $737K in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Berbice Capital Management held 20 shares of Eli Lilly worth $18.4K as of Q1 2026.
  • Berbice Capital Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.01% of Berbice Capital Management's portfolio in Q1 2026, its #120 holding.
  • Berbice Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Berbice Capital Management's Eli Lilly position peaked at $737K in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Berbice Capital Management's 13F filing for Q1 2026, filed 6 May 2026.